RYVYX
Price
$737.77
Change
+$3.04 (+0.41%)
Updated
Dec 3 closing price
Net Assets
1.58B
ULPSX
Price
$123.84
Change
+$0.74 (+0.60%)
Updated
Dec 3 closing price
Net Assets
209.27M
Interact to see
Advertisement

RYVYX vs ULPSX

Header iconRYVYX vs ULPSX Comparison
Open Charts RYVYX vs ULPSXBanner chart's image
Rydex NASDAQ-100® 2x Strategy H
Price$737.77
Change+$3.04 (+0.41%)
VolumeN/A
Net Assets1.58B
ProFunds UltraBull Svc
Price$123.84
Change+$0.74 (+0.60%)
VolumeN/A
Net Assets209.27M
RYVYX vs ULPSX Comparison Chart in %
View a ticker or compare two or three
VS
RYVYX vs. ULPSX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYVYX is a Buy and ULPSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYVYX has more cash in the bank: 1.58B vs. ULPSX (209M). ULPSX pays higher dividends than RYVYX: ULPSX (0.48) vs RYVYX (0.00). RYVYX was incepted earlier than ULPSX: RYVYX (26 years) vs ULPSX (28 years). ULPSX (2.53) is less costly to investors than RYVYX (1.87). RYVYX is a more actively managed with annual turnover of: 383.00 vs. ULPSX (217.00). RYVYX has a lower initial minimum investment than ULPSX: RYVYX (2500) vs ULPSX (15000). RYVYX annual gain was more profitable for investors over the last year : 21.89 vs. ULPSX (12.92). RYVYX return over 5 years is better than : 112.91 vs. ULPSX (69.20).
RYVYXULPSXRYVYX / ULPSX
Total Expense Ratio1.742.5369%
Annual Report Gross Expense Ratio1.872.5374%
Fund Existence26 years28 years-
Gain YTD31.36023.955131%
Front LoadN/AN/A-
Min. Initial Investment25001500017%
Min. Initial Investment IRAN/AN/A-
Net Assets1.58B209M758%
Annual Yield % from dividends0.000.48-
Returns for 1 year21.8912.92169%
Returns for 3 years214.9089.01241%
Returns for 5 years112.9169.20163%
Returns for 10 years746.42311.38240%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MUHLX74.89N/A
N/A
Muhlenkamp
STPAX24.02N/A
N/A
Saratoga Technology & Comm A
CEKYX17.12N/A
N/A
Columbia Emerging Markets Inst3
MGISX33.50N/A
N/A
Morgan Stanley Inst Global Franchise R6
JHUKX40.74N/A
N/A
JPMorgan Emerging Markets Equity R4